Shabana Shahanavaz, Athar M Qureshi, Christopher J Petit, Bryan H Goldstein, Andrew C Glatz, Holly D Bauser-Heaton, Courtney E McCracken, Michael S Kelleman, Mark A Law, George T Nicholson, Jeffrey D Zampi, Joelle Pettus, Jeffery Meadows
BACKGROUND: Stenting of the patent ductus arteriosus (PDA) is an established palliative option for infants with ductal-dependent pulmonary blood flow. Following initial palliation, reintervention on the PDA stent is common, but risk factors have not been characterized. METHODS: Infants with ductal-dependent pulmonary blood flow palliated with PDA stent between 2008 and 2015 were reviewed within the Congenital Cardiac Research Collaborative. Rates and risk factors for reintervention were analyzed...
November 18, 2021: Circulation. Cardiovascular Interventions